House Committee Seeks Information On Marketing, ‘Bundling’ Contracts Related To Anemia Medications

The House Energy and Commerce Committee has asked Amgen and Johnson & Johnson to submit information on marketing and “bundling” contracts related to anemia medications, which reports have linked with increased risk for death when administered at high doses,

More: continued here

Filed under: Pharma Industry on April 2nd, 2008